Tag: ramucirumab

Lilly’s ramucirumab fails to crack phase 3 gastric cancer trial

Eli Lilly and Company, which is better known as Lilly, says that a late-stage trial of Cyramza (ramucirumab) for the treatment of a form of ... Read More